Tracleer (bosentan), the first ORAL drug approved for pulmonary arterial hypertension

February 2002

Actelion Pharmaceuticals is now promoting Tracleer (bosentan), the first ORAL drug approved for pulmonary arterial hypertension.

Pulmonary arterial hypertension is a rare but deadly disorder. It often leads to heart failure and death within 3 years.

Usual treatments include anticoagulants...calcium channel blockers...continuous IV infusions of Flolan (epoprostenol)...or surgery.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

ibuprofen might reduce the benefit of taking low-dose ASA
Practice chart of new drugs approved by the FDA in 2001
Diabetes NovoRapid (insulin aspart), a new rapid-acting insulin analog
Infectious Diseases single-dose or three-day regimens of Zithromax (azithromycin) for acute otitis media in children
Infectious Diseases HIV patients taking the new Videx EC capsules
Hematology & Oncology Arimidex (anastrozole) is more effective than tamoxifen for EARLY breast cancer
Cardiology Tracleer (bosentan), the first ORAL drug approved for pulmonary arterial hypertension
Cardiology whether to treat patients with "white-coat hypertension
Cardiology iron supplements can suppress the cough caused by ACE inhibitors
frequent use of triptans (Imitrex, etc) can actually EXACERBATE migraines
Some products containing ephedra or ephedrine are now being voluntarily recalled
ginkgo can cause seizures
whether vitamin A causes hip fractures
Women's Health women ask if they can insert their birth control pill VAGINALLY
Women's Health whether antibiotics reduce the efficacy of oral contraceptives
Aerius, the new OTC non-sedating antihistamine
Alzheimer's Disease NSAIDs reduce the risk of Alzheimer's